Global Short Bowel Syndrome(SBS) Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Page: 95

Published Date: 01 Jan 2022

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Product Tags

Description

The Short Bowel Syndrome(SBS) Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Short Bowel Syndrome(SBS) Drugs market size is estimated to be worth US$  million in 2021 and is forecast to a readjusted size of USD  million by 2028 with a CAGR of  % during review period. Hospitals accounting for % of the Short Bowel Syndrome(SBS) Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Glucagon-Like Peptide-2(GLP-2) segment is altered to a % CAGR between 2022 and 2028.

Global key manufacturers of Short Bowel Syndrome(SBS) Drugs include Merck, Takeda, Emmaus Medical, Ardelyx, and Naia Pharmaceuticals, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation
Short Bowel Syndrome(SBS) Drugs market is split by Type and by Sale Channel. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Sale Channel in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Glucagon-Like Peptide-2(GLP-2)
    Growth Hormone
    Glutamine
    Other

Market segment by Sale Channel can be divided into
    Hospitals
    Clinics
    Retail Pharmacies

The key market players for global Short Bowel Syndrome(SBS) Drugs market are listed below:
    Merck
    Takeda
    Emmaus Medical
    Ardelyx
    Naia Pharmaceuticals
    Nutrinia
    OxThera
    Sancilio Pharmaceuticals
    Zealand Pharma

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Short Bowel Syndrome(SBS) Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Short Bowel Syndrome(SBS) Drugs, with price, sales, revenue and global market share of Short Bowel Syndrome(SBS) Drugs from 2019 to 2022.
Chapter 3, the Short Bowel Syndrome(SBS) Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Short Bowel Syndrome(SBS) Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, sale channel, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Short Bowel Syndrome(SBS) Drugs market forecast, by regions, type and sale channel, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Short Bowel Syndrome(SBS) Drugs.
Chapter 13, 14, and 15, to describe Short Bowel Syndrome(SBS) Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Short Bowel Syndrome(SBS) Drugs Introduction
    1.2 Market Analysis by Type
        1.2.1 Overview: Global Short Bowel Syndrome(SBS) Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
        1.2.2 Glucagon-Like Peptide-2(GLP-2)
        1.2.3 Growth Hormone
        1.2.4 Glutamine
        1.2.5 Other
    1.3 Market Analysis by Sale Channel
        1.3.1 Overview: Global Short Bowel Syndrome(SBS) Drugs Revenue by Sale Channel: 2017 Versus 2021 Versus 2028
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Retail Pharmacies
    1.4 Global Short Bowel Syndrome(SBS) Drugs Market Size & Forecast
        1.4.1 Global Short Bowel Syndrome(SBS) Drugs Sales in Value (2017 & 2021 & 2028)
        1.4.2 Global Short Bowel Syndrome(SBS) Drugs Sales in Volume (2017-2028)
        1.4.3 Global Short Bowel Syndrome(SBS) Drugs Price (2017-2028)
    1.5 Global Short Bowel Syndrome(SBS) Drugs Production Capacity Analysis
        1.5.1 Global Short Bowel Syndrome(SBS) Drugs Total Production Capacity (2017-2028)
        1.5.2 Global Short Bowel Syndrome(SBS) Drugs Production Capacity by Geographic Region
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Short Bowel Syndrome(SBS) Drugs Market Drivers
        1.6.2 Short Bowel Syndrome(SBS) Drugs Market Restraints
        1.6.3 Short Bowel Syndrome(SBS) Drugs Trends Analysis

2 Manufacturers Profiles
    2.1 Merck
        2.1.1 Merck Details
        2.1.2 Merck Major Business
        2.1.3 Merck Short Bowel Syndrome(SBS) Drugs Product and Services
        2.1.4 Merck Short Bowel Syndrome(SBS) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.2 Takeda
        2.2.1 Takeda Details
        2.2.2 Takeda Major Business
        2.2.3 Takeda Short Bowel Syndrome(SBS) Drugs Product and Services
        2.2.4 Takeda Short Bowel Syndrome(SBS) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.3 Emmaus Medical
        2.3.1 Emmaus Medical Details
        2.3.2 Emmaus Medical Major Business
        2.3.3 Emmaus Medical Short Bowel Syndrome(SBS) Drugs Product and Services
        2.3.4 Emmaus Medical Short Bowel Syndrome(SBS) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.4 Ardelyx
        2.4.1 Ardelyx Details
        2.4.2 Ardelyx Major Business
        2.4.3 Ardelyx Short Bowel Syndrome(SBS) Drugs Product and Services
        2.4.4 Ardelyx Short Bowel Syndrome(SBS) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.5 Naia Pharmaceuticals
        2.5.1 Naia Pharmaceuticals Details
        2.5.2 Naia Pharmaceuticals Major Business
        2.5.3 Naia Pharmaceuticals Short Bowel Syndrome(SBS) Drugs Product and Services
        2.5.4 Naia Pharmaceuticals Short Bowel Syndrome(SBS) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.6 Nutrinia
        2.6.1 Nutrinia Details
        2.6.2 Nutrinia Major Business
        2.6.3 Nutrinia Short Bowel Syndrome(SBS) Drugs Product and Services
        2.6.4 Nutrinia Short Bowel Syndrome(SBS) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.7 OxThera
        2.7.1 OxThera Details
        2.7.2 OxThera Major Business
        2.7.3 OxThera Short Bowel Syndrome(SBS) Drugs Product and Services
        2.7.4 OxThera Short Bowel Syndrome(SBS) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.8 Sancilio Pharmaceuticals
        2.8.1 Sancilio Pharmaceuticals Details
        2.8.2 Sancilio Pharmaceuticals Major Business
        2.8.3 Sancilio Pharmaceuticals Short Bowel Syndrome(SBS) Drugs Product and Services
        2.8.4 Sancilio Pharmaceuticals Short Bowel Syndrome(SBS) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.9 Zealand Pharma
        2.9.1 Zealand Pharma Details
        2.9.2 Zealand Pharma Major Business
        2.9.3 Zealand Pharma Short Bowel Syndrome(SBS) Drugs Product and Services
        2.9.4 Zealand Pharma Short Bowel Syndrome(SBS) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

3 Short Bowel Syndrome(SBS) Drugs Breakdown Data by Manufacturer
    3.1 Global Short Bowel Syndrome(SBS) Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
    3.2 Global Short Bowel Syndrome(SBS) Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
    3.3 Key Manufacturer Market Position in Short Bowel Syndrome(SBS) Drugs
    3.4 Market Concentration Rate
        3.4.1 Top 3 Short Bowel Syndrome(SBS) Drugs Manufacturer Market Share in 2021
        3.4.2 Top 6 Short Bowel Syndrome(SBS) Drugs Manufacturer Market Share in 2021
    3.5 Global Short Bowel Syndrome(SBS) Drugs Production Capacity by Company: 2021 VS 2022
    3.6 Manufacturer by Geography: Head Office and Short Bowel Syndrome(SBS) Drugs Production Site
    3.7 New Entrant and Capacity Expansion Plans
    3.8 Mergers & Acquisitions

4 Market Analysis by Region
    4.1 Global Short Bowel Syndrome(SBS) Drugs Market Size by Region
        4.1.1 Global Short Bowel Syndrome(SBS) Drugs Sales in Volume by Region (2017-2028)
        4.1.2 Global Short Bowel Syndrome(SBS) Drugs Revenue by Region (2017-2028)
    4.2 North America Short Bowel Syndrome(SBS) Drugs Revenue (2017-2028)
    4.3 Europe Short Bowel Syndrome(SBS) Drugs Revenue (2017-2028)
    4.4 Asia-Pacific Short Bowel Syndrome(SBS) Drugs Revenue (2017-2028)
    4.5 South America Short Bowel Syndrome(SBS) Drugs Revenue (2017-2028)
    4.6 Middle East and Africa Short Bowel Syndrome(SBS) Drugs Revenue (2017-2028)

5 Market Segment by Type
    5.1 Global Short Bowel Syndrome(SBS) Drugs Sales in Volume by Type (2017-2028)
    5.2 Global Short Bowel Syndrome(SBS) Drugs Revenue by Type (2017-2028)
    5.3 Global Short Bowel Syndrome(SBS) Drugs Price by Type (2017-2028)

6 Market Segment by Sale Channel
    6.1 Global Short Bowel Syndrome(SBS) Drugs Sales in Volume by Sale Channel (2017-2028)
    6.2 Global Short Bowel Syndrome(SBS) Drugs Revenue by Sale Channel (2017-2028)
    6.3 Global Short Bowel Syndrome(SBS) Drugs Price by Sale Channel (2017-2028)

7 North America by Country, by Type, and by Sale Channel
    7.1 North America Short Bowel Syndrome(SBS) Drugs Sales by Type (2017-2028)
    7.2 North America Short Bowel Syndrome(SBS) Drugs Sales by Sale Channel (2017-2028)
    7.3 North America Short Bowel Syndrome(SBS) Drugs Market Size by Country
        7.3.1 North America Short Bowel Syndrome(SBS) Drugs Sales in Volume by Country (2017-2028)
        7.3.2 North America Short Bowel Syndrome(SBS) Drugs Revenue by Country (2017-2028)
        7.3.3 United States Market Size and Forecast (2017-2028)
        7.3.4 Canada Market Size and Forecast (2017-2028)
        7.3.5 Mexico Market Size and Forecast (2017-2028)

8 Europe by Country, by Type, and by Sale Channel
    8.1 Europe Short Bowel Syndrome(SBS) Drugs Sales by Type (2017-2028)
    8.2 Europe Short Bowel Syndrome(SBS) Drugs Sales by Sale Channel (2017-2028)
    8.3 Europe Short Bowel Syndrome(SBS) Drugs Market Size by Country
        8.3.1 Europe Short Bowel Syndrome(SBS) Drugs Sales in Volume by Country (2017-2028)
        8.3.2 Europe Short Bowel Syndrome(SBS) Drugs Revenue by Country (2017-2028)
        8.3.3 Germany Market Size and Forecast (2017-2028)
        8.3.4 France Market Size and Forecast (2017-2028)
        8.3.5 United Kingdom Market Size and Forecast (2017-2028)
        8.3.6 Russia Market Size and Forecast (2017-2028)
        8.3.7 Italy Market Size and Forecast (2017-2028)

9 Asia-Pacific by Region, by Type, and by Sale Channel
    9.1 Asia-Pacific Short Bowel Syndrome(SBS) Drugs Sales by Type (2017-2028)
    9.2 Asia-Pacific Short Bowel Syndrome(SBS) Drugs Sales by Sale Channel (2017-2028)
    9.3 Asia-Pacific Short Bowel Syndrome(SBS) Drugs Market Size by Region
        9.3.1 Asia-Pacific Short Bowel Syndrome(SBS) Drugs Sales in Volume by Region (2017-2028)
        9.3.2 Asia-Pacific Short Bowel Syndrome(SBS) Drugs Revenue by Region (2017-2028)
        9.3.3 China Market Size and Forecast (2017-2028)
        9.3.4 Japan Market Size and Forecast (2017-2028)
        9.3.5 Korea Market Size and Forecast (2017-2028)
        9.3.6 India Market Size and Forecast (2017-2028)
        9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
        9.3.8 Australia Market Size and Forecast (2017-2028)

10 South America by Region, by Type, and by Sale Channel
    10.1 South America Short Bowel Syndrome(SBS) Drugs Sales by Type (2017-2028)
    10.2 South America Short Bowel Syndrome(SBS) Drugs Sales by Sale Channel (2017-2028)
    10.3 South America Short Bowel Syndrome(SBS) Drugs Market Size by Country
        10.3.1 South America Short Bowel Syndrome(SBS) Drugs Sales in Volume by Country (2017-2028)
        10.3.2 South America Short Bowel Syndrome(SBS) Drugs Revenue by Country (2017-2028)
        10.3.3 Brazil Market Size and Forecast (2017-2028)
        10.3.4 Argentina Market Size and Forecast (2017-2028)

11 Middle East & Africa by Country, by Type, and by Sale Channel
    11.1 Middle East & Africa Short Bowel Syndrome(SBS) Drugs Sales by Type (2017-2028)
    11.2 Middle East & Africa Short Bowel Syndrome(SBS) Drugs Sales by Sale Channel (2017-2028)
    11.3 Middle East & Africa Short Bowel Syndrome(SBS) Drugs Market Size by Country
        11.3.1 Middle East & Africa Short Bowel Syndrome(SBS) Drugs Sales in Volume by Country (2017-2028)
        11.3.2 Middle East & Africa Short Bowel Syndrome(SBS) Drugs Revenue by Country (2017-2028)
        11.3.3 Turkey Market Size and Forecast (2017-2028)
        11.3.4 Egypt Market Size and Forecast (2017-2028)
        11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
        11.3.6 South Africa Market Size and Forecast (2017-2028)

12 Raw Material and Industry Chain
    12.1 Raw Material of Short Bowel Syndrome(SBS) Drugs and Key Manufacturers
    12.2 Manufacturing Costs Percentage of Short Bowel Syndrome(SBS) Drugs
    12.3 Short Bowel Syndrome(SBS) Drugs Production Process
    12.4 Short Bowel Syndrome(SBS) Drugs Industrial Chain

13 Sales Channel, Distributors, Traders and Dealers
    13.1 Sales Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
    13.2 Short Bowel Syndrome(SBS) Drugs Typical Distributors
    13.3 Short Bowel Syndrome(SBS) Drugs Typical Customers

14 Research Findings and Conclusion

15 Appendix
    15.1 Methodology
    15.2 Research Process and Data Source
    15.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Short Bowel Syndrome(SBS) Drugs Revenue by Type, (USD Million), 2017 & 2021 & 2028
    Table 2. Global Short Bowel Syndrome(SBS) Drugs Revenue by Sale Channel, (USD Million), 2017 & 2021 & 2028
    Table 3. Merck Basic Information, Manufacturing Base and Competitors
    Table 4. Merck Major Business
    Table 5. Merck Short Bowel Syndrome(SBS) Drugs Product and Services
    Table 6. Merck Short Bowel Syndrome(SBS) Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 7. Takeda Basic Information, Manufacturing Base and Competitors
    Table 8. Takeda Major Business
    Table 9. Takeda Short Bowel Syndrome(SBS) Drugs Product and Services
    Table 10. Takeda Short Bowel Syndrome(SBS) Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 11. Emmaus Medical Basic Information, Manufacturing Base and Competitors
    Table 12. Emmaus Medical Major Business
    Table 13. Emmaus Medical Short Bowel Syndrome(SBS) Drugs Product and Services
    Table 14. Emmaus Medical Short Bowel Syndrome(SBS) Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 15. Ardelyx Basic Information, Manufacturing Base and Competitors
    Table 16. Ardelyx Major Business
    Table 17. Ardelyx Short Bowel Syndrome(SBS) Drugs Product and Services
    Table 18. Ardelyx Short Bowel Syndrome(SBS) Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 19. Naia Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 20. Naia Pharmaceuticals Major Business
    Table 21. Naia Pharmaceuticals Short Bowel Syndrome(SBS) Drugs Product and Services
    Table 22. Naia Pharmaceuticals Short Bowel Syndrome(SBS) Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 23. Nutrinia Basic Information, Manufacturing Base and Competitors
    Table 24. Nutrinia Major Business
    Table 25. Nutrinia Short Bowel Syndrome(SBS) Drugs Product and Services
    Table 26. Nutrinia Short Bowel Syndrome(SBS) Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 27. OxThera Basic Information, Manufacturing Base and Competitors
    Table 28. OxThera Major Business
    Table 29. OxThera Short Bowel Syndrome(SBS) Drugs Product and Services
    Table 30. OxThera Short Bowel Syndrome(SBS) Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 31. Sancilio Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 32. Sancilio Pharmaceuticals Major Business
    Table 33. Sancilio Pharmaceuticals Short Bowel Syndrome(SBS) Drugs Product and Services
    Table 34. Sancilio Pharmaceuticals Short Bowel Syndrome(SBS) Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 35. Zealand Pharma Basic Information, Manufacturing Base and Competitors
    Table 36. Zealand Pharma Major Business
    Table 37. Zealand Pharma Short Bowel Syndrome(SBS) Drugs Product and Services
    Table 38. Zealand Pharma Short Bowel Syndrome(SBS) Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 39. Global Short Bowel Syndrome(SBS) Drugs Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Pcs)
    Table 40. Global Short Bowel Syndrome(SBS) Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
    Table 41. Market Position of Manufacturers in Short Bowel Syndrome(SBS) Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
    Table 42. Global Short Bowel Syndrome(SBS) Drugs Production Capacity by Company, (K Pcs): 2020 VS 2021
    Table 43. Head Office and Short Bowel Syndrome(SBS) Drugs Production Site of Key Manufacturer
    Table 44. Short Bowel Syndrome(SBS) Drugs New Entrant and Capacity Expansion Plans
    Table 45. Short Bowel Syndrome(SBS) Drugs Mergers & Acquisitions in the Past Five Years
    Table 46. Global Short Bowel Syndrome(SBS) Drugs Sales by Region (2017-2022) & (K Pcs)
    Table 47. Global Short Bowel Syndrome(SBS) Drugs Sales by Region (2023-2028) & (K Pcs)
    Table 48. Global Short Bowel Syndrome(SBS) Drugs Revenue by Region (2017-2022) & (USD Million)
    Table 49. Global Short Bowel Syndrome(SBS) Drugs Revenue by Region (2023-2028) & (USD Million)
    Table 50. Global Short Bowel Syndrome(SBS) Drugs Sales by Type (2017-2022) & (K Pcs)
    Table 51. Global Short Bowel Syndrome(SBS) Drugs Sales by Type (2023-2028) & (K Pcs)
    Table 52. Global Short Bowel Syndrome(SBS) Drugs Revenue by Type (2017-2022) & (USD Million)
    Table 53. Global Short Bowel Syndrome(SBS) Drugs Revenue by Type (2023-2028) & (USD Million)
    Table 54. Global Short Bowel Syndrome(SBS) Drugs Price by Type (2017-2022) & (USD/Pcs)
    Table 55. Global Short Bowel Syndrome(SBS) Drugs Price by Type (2023-2028) & (USD/Pcs)
    Table 56. Global Short Bowel Syndrome(SBS) Drugs Sales by Sale Channel (2017-2022) & (K Pcs)
    Table 57. Global Short Bowel Syndrome(SBS) Drugs Sales by Sale Channel (2023-2028) & (K Pcs)
    Table 58. Global Short Bowel Syndrome(SBS) Drugs Revenue by Sale Channel (2017-2022) & (USD Million)
    Table 59. Global Short Bowel Syndrome(SBS) Drugs Revenue by Sale Channel (2023-2028) & (USD Million)
    Table 60. Global Short Bowel Syndrome(SBS) Drugs Price by Sale Channel (2017-2022) & (USD/Pcs)
    Table 61. Global Short Bowel Syndrome(SBS) Drugs Price by Sale Channel (2023-2028) & (USD/Pcs)
    Table 62. North America Short Bowel Syndrome(SBS) Drugs Sales by Country (2017-2022) & (K Pcs)
    Table 63. North America Short Bowel Syndrome(SBS) Drugs Sales by Country (2023-2028) & (K Pcs)
    Table 64. North America Short Bowel Syndrome(SBS) Drugs Revenue by Country (2017-2022) & (USD Million)
    Table 65. North America Short Bowel Syndrome(SBS) Drugs Revenue by Country (2023-2028) & (USD Million)
    Table 66. North America Short Bowel Syndrome(SBS) Drugs Sales by Type (2017-2022) & (K Pcs)
    Table 67. North America Short Bowel Syndrome(SBS) Drugs Sales by Type (2023-2028) & (K Pcs)
    Table 68. North America Short Bowel Syndrome(SBS) Drugs Sales by Sale Channel (2017-2022) & (K Pcs)
    Table 69. North America Short Bowel Syndrome(SBS) Drugs Sales by Sale Channel (2023-2028) & (K Pcs)
    Table 70. Europe Short Bowel Syndrome(SBS) Drugs Sales by Country (2017-2022) & (K Pcs)
    Table 71. Europe Short Bowel Syndrome(SBS) Drugs Sales by Country (2023-2028) & (K Pcs)
    Table 72. Europe Short Bowel Syndrome(SBS) Drugs Revenue by Country (2017-2022) & (USD Million)
    Table 73. Europe Short Bowel Syndrome(SBS) Drugs Revenue by Country (2023-2028) & (USD Million)
    Table 74. Europe Short Bowel Syndrome(SBS) Drugs Sales by Type (2017-2022) & (K Pcs)
    Table 75. Europe Short Bowel Syndrome(SBS) Drugs Sales by Type (2023-2028) & (K Pcs)
    Table 76. Europe Short Bowel Syndrome(SBS) Drugs Sales by Sale Channel (2017-2022) & (K Pcs)
    Table 77. Europe Short Bowel Syndrome(SBS) Drugs Sales by Sale Channel (2023-2028) & (K Pcs)
    Table 78. Asia-Pacific Short Bowel Syndrome(SBS) Drugs Sales by Region (2017-2022) & (K Pcs)
    Table 79. Asia-Pacific Short Bowel Syndrome(SBS) Drugs Sales by Region (2023-2028) & (K Pcs)
    Table 80. Asia-Pacific Short Bowel Syndrome(SBS) Drugs Revenue by Region (2017-2022) & (USD Million)
    Table 81. Asia-Pacific Short Bowel Syndrome(SBS) Drugs Revenue by Region (2023-2028) & (USD Million)
    Table 82. Asia-Pacific Short Bowel Syndrome(SBS) Drugs Sales by Type (2017-2022) & (K Pcs)
    Table 83. Asia-Pacific Short Bowel Syndrome(SBS) Drugs Sales by Type (2023-2028) & (K Pcs)
    Table 84. Asia-Pacific Short Bowel Syndrome(SBS) Drugs Sales by Sale Channel (2017-2022) & (K Pcs)
    Table 85. Asia-Pacific Short Bowel Syndrome(SBS) Drugs Sales by Sale Channel (2023-2028) & (K Pcs)
    Table 86. South America Short Bowel Syndrome(SBS) Drugs Sales by Country (2017-2022) & (K Pcs)
    Table 87. South America Short Bowel Syndrome(SBS) Drugs Sales by Country (2023-2028) & (K Pcs)
    Table 88. South America Short Bowel Syndrome(SBS) Drugs Revenue by Country (2017-2022) & (USD Million)
    Table 89. South America Short Bowel Syndrome(SBS) Drugs Revenue by Country (2023-2028) & (USD Million)
    Table 90. South America Short Bowel Syndrome(SBS) Drugs Sales by Type (2017-2022) & (K Pcs)
    Table 91. South America Short Bowel Syndrome(SBS) Drugs Sales by Type (2023-2028) & (K Pcs)
    Table 92. South America Short Bowel Syndrome(SBS) Drugs Sales by Sale Channel (2017-2022) & (K Pcs)
    Table 93. South America Short Bowel Syndrome(SBS) Drugs Sales by Sale Channel (2023-2028) & (K Pcs)
    Table 94. Middle East & Africa Short Bowel Syndrome(SBS) Drugs Sales by Region (2017-2022) & (K Pcs)
    Table 95. Middle East & Africa Short Bowel Syndrome(SBS) Drugs Sales by Region (2023-2028) & (K Pcs)
    Table 96. Middle East & Africa Short Bowel Syndrome(SBS) Drugs Revenue by Region (2017-2022) & (USD Million)
    Table 97. Middle East & Africa Short Bowel Syndrome(SBS) Drugs Revenue by Region (2023-2028) & (USD Million)
    Table 98. Middle East & Africa Short Bowel Syndrome(SBS) Drugs Sales by Type (2017-2022) & (K Pcs)
    Table 99. Middle East & Africa Short Bowel Syndrome(SBS) Drugs Sales by Type (2023-2028) & (K Pcs)
    Table 100. Middle East & Africa Short Bowel Syndrome(SBS) Drugs Sales by Sale Channel (2017-2022) & (K Pcs)
    Table 101. Middle East & Africa Short Bowel Syndrome(SBS) Drugs Sales by Sale Channel (2023-2028) & (K Pcs)
    Table 102. Short Bowel Syndrome(SBS) Drugs Raw Material
    Table 103. Key Manufacturers of Short Bowel Syndrome(SBS) Drugs Raw Materials
    Table 104. Direct Channel Pros & Cons
    Table 105. Indirect Channel Pros & Cons
    Table 106. Short Bowel Syndrome(SBS) Drugs Typical Distributors
    Table 107. Short Bowel Syndrome(SBS) Drugs Typical Customers
List of Figures
    Figure 1. Short Bowel Syndrome(SBS) Drugs Picture
    Figure 2. Global Short Bowel Syndrome(SBS) Drugs Revenue Market Share by Type in 2021
    Figure 3. Glucagon-Like Peptide-2(GLP-2)
    Figure 4. Growth Hormone
    Figure 5. Glutamine
    Figure 6. Other
    Figure 7. Global Short Bowel Syndrome(SBS) Drugs Revenue Market Share by Sale Channel in 2021
    Figure 8. Hospitals
    Figure 9. Clinics
    Figure 10. Retail Pharmacies
    Figure 11. Global Short Bowel Syndrome(SBS) Drugs Revenue, (USD Million) & (K Pcs): 2017 & 2021 & 2028
    Figure 12. Global Short Bowel Syndrome(SBS) Drugs Revenue and Forecast (2017-2028) & (USD Million)
    Figure 13. Global Short Bowel Syndrome(SBS) Drugs Sales (2017-2028) & (K Pcs)
    Figure 14. Global Short Bowel Syndrome(SBS) Drugs Price (2017-2028) & (USD/Pcs)
    Figure 15. Global Short Bowel Syndrome(SBS) Drugs Production Capacity (2017-2028) & (K Pcs)
    Figure 16. Global Short Bowel Syndrome(SBS) Drugs Production Capacity by Geographic Region: 2022 VS 2028
    Figure 17. Short Bowel Syndrome(SBS) Drugs Market Drivers
    Figure 18. Short Bowel Syndrome(SBS) Drugs Market Restraints
    Figure 19. Short Bowel Syndrome(SBS) Drugs Market Trends
    Figure 20. Global Short Bowel Syndrome(SBS) Drugs Sales Market Share by Manufacturer in 2021
    Figure 21. Global Short Bowel Syndrome(SBS) Drugs Revenue Market Share by Manufacturer in 2021
    Figure 22. Short Bowel Syndrome(SBS) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
    Figure 23. Top 3 Short Bowel Syndrome(SBS) Drugs Manufacturer (Revenue) Market Share in 2021
    Figure 24. Top 6 Short Bowel Syndrome(SBS) Drugs Manufacturer (Revenue) Market Share in 2021
    Figure 25. Global Short Bowel Syndrome(SBS) Drugs Sales Market Share by Region (2017-2028)
    Figure 26. Global Short Bowel Syndrome(SBS) Drugs Revenue Market Share by Region (2017-2028)
    Figure 27. North America Short Bowel Syndrome(SBS) Drugs Revenue (2017-2028) & (USD Million)
    Figure 28. Europe Short Bowel Syndrome(SBS) Drugs Revenue (2017-2028) & (USD Million)
    Figure 29. Asia-Pacific Short Bowel Syndrome(SBS) Drugs Revenue (2017-2028) & (USD Million)
    Figure 30. South America Short Bowel Syndrome(SBS) Drugs Revenue (2017-2028) & (USD Million)
    Figure 31. Middle East & Africa Short Bowel Syndrome(SBS) Drugs Revenue (2017-2028) & (USD Million)
    Figure 32. Global Short Bowel Syndrome(SBS) Drugs Sales Market Share by Type (2017-2028)
    Figure 33. Global Short Bowel Syndrome(SBS) Drugs Revenue Market Share by Type (2017-2028)
    Figure 34. Global Short Bowel Syndrome(SBS) Drugs Price by Type (2017-2028) & (USD/Pcs)
    Figure 35. Global Short Bowel Syndrome(SBS) Drugs Sales Market Share by Sale Channel (2017-2028)
    Figure 36. Global Short Bowel Syndrome(SBS) Drugs Revenue Market Share by Sale Channel (2017-2028)
    Figure 37. Global Short Bowel Syndrome(SBS) Drugs Price by Sale Channel (2017-2028) & (USD/Pcs)
    Figure 38. North America Short Bowel Syndrome(SBS) Drugs Sales Market Share by Type (2017-2028)
    Figure 39. North America Short Bowel Syndrome(SBS) Drugs Sales Market Share by Sale Channel (2017-2028)
    Figure 40. North America Short Bowel Syndrome(SBS) Drugs Sales Market Share by Country (2017-2028)
    Figure 41. North America Short Bowel Syndrome(SBS) Drugs Revenue Market Share by Country (2017-2028)
    Figure 42. United States Short Bowel Syndrome(SBS) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 43. Canada Short Bowel Syndrome(SBS) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 44. Mexico Short Bowel Syndrome(SBS) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 45. Europe Short Bowel Syndrome(SBS) Drugs Sales Market Share by Type (2017-2028)
    Figure 46. Europe Short Bowel Syndrome(SBS) Drugs Sales Market Share by Sale Channel (2017-2028)
    Figure 47. Europe Short Bowel Syndrome(SBS) Drugs Sales Market Share by Country (2017-2028)
    Figure 48. Europe Short Bowel Syndrome(SBS) Drugs Revenue Market Share by Country (2017-2028)
    Figure 49. Germany Short Bowel Syndrome(SBS) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 50. France Short Bowel Syndrome(SBS) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 51. United Kingdom Short Bowel Syndrome(SBS) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 52. Russia Short Bowel Syndrome(SBS) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 53. Italy Short Bowel Syndrome(SBS) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 54. Asia-Pacific Short Bowel Syndrome(SBS) Drugs Sales Market Share by Region (2017-2028)
    Figure 55. Asia-Pacific Short Bowel Syndrome(SBS) Drugs Sales Market Share by Sale Channel (2017-2028)
    Figure 56. Asia-Pacific Short Bowel Syndrome(SBS) Drugs Sales Market Share by Region (2017-2028)
    Figure 57. Asia-Pacific Short Bowel Syndrome(SBS) Drugs Revenue Market Share by Region (2017-2028)
    Figure 58. China Short Bowel Syndrome(SBS) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 59. Japan Short Bowel Syndrome(SBS) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 60. Korea Short Bowel Syndrome(SBS) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 61. India Short Bowel Syndrome(SBS) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 62. Southeast Asia Short Bowel Syndrome(SBS) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 63. Australia Short Bowel Syndrome(SBS) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 64. South America Short Bowel Syndrome(SBS) Drugs Sales Market Share by Type (2017-2028)
    Figure 65. South America Short Bowel Syndrome(SBS) Drugs Sales Market Share by Sale Channel (2017-2028)
    Figure 66. South America Short Bowel Syndrome(SBS) Drugs Sales Market Share by Country (2017-2028)
    Figure 67. South America Short Bowel Syndrome(SBS) Drugs Revenue Market Share by Country (2017-2028)
    Figure 68. Brazil Short Bowel Syndrome(SBS) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 69. Argentina Short Bowel Syndrome(SBS) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 70. Middle East & Africa Short Bowel Syndrome(SBS) Drugs Sales Market Share by Type (2017-2028)
    Figure 71. Middle East & Africa Short Bowel Syndrome(SBS) Drugs Sales Market Share by Sale Channel (2017-2028)
    Figure 72. Middle East & Africa Short Bowel Syndrome(SBS) Drugs Sales Market Share by Region (2017-2028)
    Figure 73. Middle East & Africa Short Bowel Syndrome(SBS) Drugs Revenue Market Share by Region (2017-2028)
    Figure 74. Turkey Short Bowel Syndrome(SBS) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 75. Egypt Short Bowel Syndrome(SBS) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 76. Saudi Arabia Short Bowel Syndrome(SBS) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 77. South Africa Short Bowel Syndrome(SBS) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 78. Manufacturing Cost Structure Analysis of Short Bowel Syndrome(SBS) Drugs in 2021
    Figure 79. Manufacturing Process Analysis of Short Bowel Syndrome(SBS) Drugs
    Figure 80. Short Bowel Syndrome(SBS) Drugs Industrial Chain
    Figure 81. Sales Channel: Direct Channel vs Indirect Channel
    Figure 82. Methodology
    Figure 83. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Merck
Takeda
Emmaus Medical
Ardelyx
Naia Pharmaceuticals
Nutrinia
OxThera
Sancilio Pharmaceuticals
Zealand Pharma

Product Tags

short bowel syndrome sbs drugs

Short Bowel Syndrome (SBS) Drugs

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>